CLEC2D and prostate cancer: In the present study, we observed LLT1 expression on hormone-refractory prostate cancer cell lines DU145, PC3, 22Rv1, hormone-sensitive LNCaP cells, normal prostate cells PWR-1E and acute T leukemia cell Jurkat both at the mRNA and protein level.